Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
- [o.204] Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study (0)
- [o.295] The XTEND-CIU study: long term use of omalizumab in chronic idiopathic urticaria (0)
- [o.205] Hereditary angioedema: Molecular and clinicaldifferences among European populations (0)
- [o.294] Cyclosporine for chronic spontaneous urticaria: a meta-analysis and systematic review (0)
- [o.206] Impact of psoriasis severity on family income and quality of life (0)
- [o.207] Impaired T-cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome (0)
- [o.293] In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angioedema (0)
- [o.208] Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus (0)
- [o.292] Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant (0)
- [o.291] Comparison and interpretability of the available urticaria activity scores (0)
- [o.290] Mast cells are critical for the limitation of thrombin-induced skin inflammation (0)
- [o.289] Genetic determinants of C1 inhibitor deficiency angioedema age of onset (0)
- [o.287] Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria (0)
- [o.286] Chronic urticaria in most patients is poorly controlled: Results of the development, validation, and real life application of the Arabic urticaria control test (0)
- [o.285] The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU (0)
- [o.279] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the icatibant outcome survey (0)
- [o.209] Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria (0)
- [o.277] Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema (0)
- [o.276] Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling (0)
- [o.211] Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy (0)
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.